Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Fentolamin
2. Mesilate, Phentolamine
3. Mesylate, Phentolamine
4. Methanesulfonate, Phentolamine
5. Mono-hydrochloride, Phentolamine
6. Phentolamine
7. Phentolamine Mesilate
8. Phentolamine Methanesulfonate
9. Phentolamine Mono Hydrochloride
10. Phentolamine Mono-hydrochloride
11. Regitine
12. Regityn
13. Rogitine
14. Z-max
1. 65-28-1
2. Phentolamine Mesilate
3. Phentolamine Methanesulfonate
4. Phentolamine (mesylate)
5. Oraverse
6. Regitine Mesylate
7. Phentolamine Methanesulfonate Salt
8. Phentolamine Mesylate [usp]
9. Mesylate Phentolamine
10. 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(p-tolyl)amino)phenol Methanesulfonate
11. Nv-101
12. Mls000069487
13. Y7543e5k9t
14. M-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)phenol Monomethanesulfonate (salt)
15. Phenol, 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, Monomethanesulfonate (salt)
16. Phenol,3-[[(4,5-dihydro-1h-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt)
17. Smr000059054
18. 3-[n-(4,5-dihydro-1h-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic Acid
19. Phentolamine Mesylate (usp)
20. Vasomax
21. Regitin Methanesulphonate
22. Regitine Methanesulfonate
23. Phenol, M-[n-(2-imidazolin-2-ylmethyl)-p-toluidino]-, Methanesulfonate (1:1)
24. Phentolamine Methanesulphonate
25. Ccris 9022
26. Phentolamine Mesilate [inn:ban]
27. Einecs 200-604-6
28. Vasofem
29. Unii-y7543e5k9t
30. Regitin Mesylate
31. Sr-01000000055
32. Regitine (tn)
33. Z-max
34. Mfcd00134201
35. Opera_id_1599
36. Lopac-p-7561
37. Phentolamine Meslate,(s)
38. Schembl40852
39. Mls001076484
40. Phentolamine, Methyl Sulfonate
41. Regid_for_cid_91430
42. Chembl1200873
43. Hy-b0362a
44. Dtxsid60215315
45. Phentolamine Mesilate (jan/inn)
46. Hms2233a24
47. Hms3263e05
48. Hms3373d03
49. Hms3655b13
50. Hms3884a22
51. Phentolamine Mesilate [jan]
52. Bcp09845
53. Tox21_500982
54. Phentolamine Mesylate [vandf]
55. S2038
56. 3-fluoropyridine-4-boronicacidhydrate
57. Phentolamine Mesilate [mart.]
58. Akos007930193
59. Phentolamine Mesilate [who-dd]
60. Phentolamine Mesylate [usp-rs]
61. Ac-7472
62. Ccg-222286
63. Lp00982
64. 3-[n-(4,5-dihydro-1h-imidazol-2-ylmethyl)-4-methylanilino]phenol; Methanesulfonic Acid
65. Phenol, M-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)-, Monomethanesulfonate (salt)
66. Ncgc00016195-01
67. Ncgc00016195-02
68. Ncgc00094282-01
69. Ncgc00261667-01
70. As-13800
71. Phentolamine Methanesulfonate [mi]
72. Phentolamine Mesylate [orange Book]
73. Phentolamine Mesilate [ep Monograph]
74. Eu-0100982
75. Ft-0603267
76. P1985
77. Phentolamine Mesylate [usp Monograph]
78. Sw196637-3
79. D00509
80. P 7561
81. T72782
82. 134p201
83. A835046
84. Sr-01000000055-3
85. W-104799
86. Q27294332
87. Phentolamine Methanesulfonate Salt, >=98% (tlc), Powder
88. Phentolamine Mesilate, British Pharmacopoeia (bp) Reference Standard
89. 2-[n-(m-hydroxyphenyl)-p-toluidinomethyl]imidazoline Methanesulfonate
90. Phentolamine Mesilate, European Pharmacopoeia (ep) Reference Standard
91. Phentolamine Mesylate, United States Pharmacopeia (usp) Reference Standard
92. 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(p-tolyl)amino)phenolmethanesulfonate
93. 3-[[(4,5-dihydro-1h-imidazol-2-yl)methyl](4-methylphenyl)amino]phenol Methanesulfonate
94. 3-[4,5-dihydro-1h-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol; Methanesulfonic Acid
95. 3-[n-(4,5-dihydro-1h-imidazol-1-ium-2-ylmethyl)-4-methylanilino]phenol;methanesulfonate
96. M-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)phenol Monomethanesulphonate (salt)
97. Phentolamine Mesilate For System Suitability, European Pharmacopoeia (ep) Reference Standard
98. Phentolamine Mesylate, Pharmaceutical Secondary Standard; Certified Reference Material
99. Phenol, 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, Monomethanesulphonate (salt)
Molecular Weight | 377.5 g/mol |
---|---|
Molecular Formula | C18H23N3O4S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 377.14092740 g/mol |
Monoisotopic Mass | 377.14092740 g/mol |
Topological Polar Surface Area | 111 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 456 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Phentolamine mesylate |
Drug Label | Phentolamine Mesylate for Injection USP, is an antihypertensive, available in vials for intravenous and intramuscular administration. Each vial contains phentolamine mesylate USP, 5 mg and mannitol USP, 25 mg in sterile, lyophilized form.Phentolamine... |
Active Ingredient | Phentolamine mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | 5mg/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
2 of 4 | |
---|---|
Drug Name | Oraverse |
PubMed Health | Phentolamine (Injection) |
Drug Classes | Antihypertensive, Diagnostic Agent, Pheochromocytoma, Toxicology-Antidote Agent |
Drug Label | Phentolamine mesylate is phenol,3-[[(4,5-dihydro-1 H-imidazol-2-yl)methyl](4-methyl-phenyl)amino]-, methanesulfonate (salt), a non-specific alpha adrenergic blocker.Phentolamine mesylate USP is a white to off-white, odorless crystalline powder with a... |
Active Ingredient | Phentolamine mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | 0.4mg/1.7ml |
Market Status | Prescription |
Company | Septodont Holding |
3 of 4 | |
---|---|
Drug Name | Phentolamine mesylate |
Drug Label | Phentolamine Mesylate for Injection USP, is an antihypertensive, available in vials for intravenous and intramuscular administration. Each vial contains phentolamine mesylate USP, 5 mg and mannitol USP, 25 mg in sterile, lyophilized form.Phentolamine... |
Active Ingredient | Phentolamine mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | 5mg/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
4 of 4 | |
---|---|
Drug Name | Oraverse |
PubMed Health | Phentolamine (Injection) |
Drug Classes | Antihypertensive, Diagnostic Agent, Pheochromocytoma, Toxicology-Antidote Agent |
Drug Label | Phentolamine mesylate is phenol,3-[[(4,5-dihydro-1 H-imidazol-2-yl)methyl](4-methyl-phenyl)amino]-, methanesulfonate (salt), a non-specific alpha adrenergic blocker.Phentolamine mesylate USP is a white to off-white, odorless crystalline powder with a... |
Active Ingredient | Phentolamine mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | 0.4mg/1.7ml |
Market Status | Prescription |
Company | Septodont Holding |
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Phentolamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phentolamine Mesylate, including repackagers and relabelers. The FDA regulates Phentolamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phentolamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Phentolamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Phentolamine Mesylate supplier is an individual or a company that provides Phentolamine Mesylate active pharmaceutical ingredient (API) or Phentolamine Mesylate finished formulations upon request. The Phentolamine Mesylate suppliers may include Phentolamine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Phentolamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Phentolamine Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Phentolamine Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Phentolamine Mesylate DMFs exist exist since differing nations have different regulations, such as Phentolamine Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Phentolamine Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Phentolamine Mesylate USDMF includes data on Phentolamine Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Phentolamine Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Phentolamine Mesylate suppliers with USDMF on PharmaCompass.
A Phentolamine Mesylate CEP of the European Pharmacopoeia monograph is often referred to as a Phentolamine Mesylate Certificate of Suitability (COS). The purpose of a Phentolamine Mesylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Phentolamine Mesylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Phentolamine Mesylate to their clients by showing that a Phentolamine Mesylate CEP has been issued for it. The manufacturer submits a Phentolamine Mesylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Phentolamine Mesylate CEP holder for the record. Additionally, the data presented in the Phentolamine Mesylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Phentolamine Mesylate DMF.
A Phentolamine Mesylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Phentolamine Mesylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Phentolamine Mesylate suppliers with CEP (COS) on PharmaCompass.
A Phentolamine Mesylate written confirmation (Phentolamine Mesylate WC) is an official document issued by a regulatory agency to a Phentolamine Mesylate manufacturer, verifying that the manufacturing facility of a Phentolamine Mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Phentolamine Mesylate APIs or Phentolamine Mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Phentolamine Mesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Phentolamine Mesylate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Phentolamine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Phentolamine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Phentolamine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Phentolamine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Phentolamine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Phentolamine Mesylate suppliers with NDC on PharmaCompass.
Phentolamine Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Phentolamine Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Phentolamine Mesylate GMP manufacturer or Phentolamine Mesylate GMP API supplier for your needs.
A Phentolamine Mesylate CoA (Certificate of Analysis) is a formal document that attests to Phentolamine Mesylate's compliance with Phentolamine Mesylate specifications and serves as a tool for batch-level quality control.
Phentolamine Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Phentolamine Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Phentolamine Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Phentolamine Mesylate EP), Phentolamine Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Phentolamine Mesylate USP).
LOOKING FOR A SUPPLIER?